These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

759 related items for PubMed ID: 17530668

  • 1. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
    Huo TI, Hsia CY, Chu CJ, Huang YH, Lui WY, Wu JC, Lee PC, Chi CW, Lee SD.
    J Surg Oncol; 2007 Jun 15; 95(8):645-51. PubMed ID: 17530668
    [Abstract] [Full Text] [Related]

  • 2. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 15; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R.
    Am J Gastroenterol; 2000 Apr 15; 95(4):1036-40. PubMed ID: 10763956
    [Abstract] [Full Text] [Related]

  • 4. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G.
    Hepatogastroenterology; 2000 Apr 15; 47(36):1654-8. PubMed ID: 11149026
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G.
    Anticancer Res; 2003 Apr 15; 23(2C):1747-53. PubMed ID: 12820452
    [Abstract] [Full Text] [Related]

  • 6. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH.
    Clin Cancer Res; 2008 Jan 15; 14(2):470-7. PubMed ID: 18223221
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P, Chanmee T, Komtong S, Mahachai V, Wisedopas N, Pothacharoen P, Kongtawelert P.
    J Gastroenterol Hepatol; 2010 Jan 15; 25(1):129-37. PubMed ID: 19793164
    [Abstract] [Full Text] [Related]

  • 8. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
    Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, Satomura S, Schwartz ME.
    Am J Gastroenterol; 2007 Oct 15; 102(10):2196-205. PubMed ID: 17617202
    [Abstract] [Full Text] [Related]

  • 9. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC, Chan CS, Chen GH.
    Hepatogastroenterology; 1999 Oct 15; 46(30):3208-11. PubMed ID: 10626187
    [Abstract] [Full Text] [Related]

  • 10. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
    Park Y, Park Y, Lim HS, Kim YS, Hong DJ, Kim HS.
    Tissue Antigens; 2012 Feb 15; 79(2):97-103. PubMed ID: 22136460
    [Abstract] [Full Text] [Related]

  • 11. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
    Huo TI, Huang YH, Lui WY, Wu JC, Lee PC, Chang FY, Lee SD.
    Oncol Rep; 2004 Feb 15; 11(2):543-50. PubMed ID: 14719097
    [Abstract] [Full Text] [Related]

  • 12. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L.
    J Gastroenterol Hepatol; 2009 Jan 15; 24(1):55-62. PubMed ID: 18823443
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
    Wang Y, Liu YH, Mai SJ, He LJ, Liao YJ, Deng HX, Guan XY, Zeng YX, Kung HF, Xie D.
    J Gastroenterol Hepatol; 2010 Jun 15; 25(6):1123-8. PubMed ID: 20594228
    [Abstract] [Full Text] [Related]

  • 14. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ, Yu GR, Park SH, Cho BH, Ahn JS, Park HJ, Song EY, Kim DG.
    Clin Cancer Res; 2008 Feb 15; 14(4):1080-9. PubMed ID: 18281540
    [Abstract] [Full Text] [Related]

  • 15. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.
    Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS.
    Hepatology; 2003 May 15; 37(5):1114-21. PubMed ID: 12717392
    [Abstract] [Full Text] [Related]

  • 16. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T.
    Int J Mol Med; 2002 Mar 15; 9(3):245-50. PubMed ID: 11836630
    [Abstract] [Full Text] [Related]

  • 17. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG, Mathews S, Jayanthi V, Shankar EM, Hari R, Surendran R, Vengatesan A, Raghuram K, Rajasambandam P, Murali A, Srinivas U, Palaniswamy KR, Pugazhendhi T, Thyagarajan SP.
    Int J Infect Dis; 2008 Nov 15; 12(6):e71-6. PubMed ID: 18658001
    [Abstract] [Full Text] [Related]

  • 18. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K, Watanabe T, Aikawa K, Toshima M, Shibasaki K, Aoyagi Y.
    Hepatogastroenterology; 1998 Nov 15; 45(23):1737-41. PubMed ID: 9840138
    [Abstract] [Full Text] [Related]

  • 19. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
    Sun GZ, Zhao XY, Li JH, Zhao GQ, Wang SX, Kong SL.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1986-8. PubMed ID: 19062741
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
    Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, Rapaccini G, Del Poggio P, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Bernardi M, Trevisani F.
    Am J Gastroenterol; 2006 Mar 22; 101(3):524-32. PubMed ID: 16542289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.